VHCP Management II’s Ascendis Pharma A/S ASND Stock Holding History

VHCP Management II’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-234,591	Closed	-$22.6M	–	21
2019 Q3	$22.6M	Sell	234,591 -269,619	-53%	-$30.1M	8.61%	3
2019 Q2	$58.1M	Hold	504,210	–	–	18.3%	1
2019 Q1	$59.3M	Hold	504,210	–	–	17.37%	1
2018 Q4	$31.6M	Hold	504,210	–	–	13.56%	2
2018 Q3	$35.7M	Hold	504,210	–	–	9.54%	4
2018 Q2	$33.5M	Sell	504,210 -81,985	-14%	-$5.39M	10.04%	4
2018 Q1	$38.3M	Sell	586,195 -526,819	-47%	-$29.6M	9.25%	3
2017 Q4	$44.6M	Sell	1,113,014 -186,038	-14%	-$6.76M	10.69%	3
2017 Q3	$47.1M	Buy	1,299,052 +312,560	+32%	+$8.97M	13.01%	3
2017 Q2	$27.4M	Buy	986,492 +175,000	+22%	+$4.62M	10.94%	3
2017 Q1	$22.7M	Buy	811,492 +90,340	+13%	+$2.28M	9.3%	3
2016 Q4	$14.6M	Hold	721,152	–	–	7%	5
2016 Q3	$14.5M	Hold	721,152	–	–	7.44%	5
2016 Q2	$9.57M	Hold	721,152	–	–	5.78%	5
2016 Q1	$13.4M	Hold	721,152	–	–	8.8%	3
2015 Q4	$13.2M	Buy	+721,152	New	+$12.6M	10.85%	4

Other funds holding ASND

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

VHCP Management II's ASND Position: Q4 2019 in Review

VHCP Management II sold out of Ascendis Pharma A/S (ASND) in Q4 2019, closing a stake of 234,591 shares — an estimated $22.6M sold.

VHCP Management II first reported a position in ASND in Q4 2015 and held it in 16 quarters. The position peaked at $59.3M in Q1 2019. 143 funds tracked by Wall St. Rank hold ASND as of Q4 2019.

VHCP Management II reported no remaining Ascendis Pharma A/S position as of Q4 2019 after selling out during the quarter.
VHCP Management II sold 234,591 Ascendis Pharma A/S shares in Q4 2019, an estimated $22.6M.
VHCP Management II first reported a position in Ascendis Pharma A/S in Q4 2015 and held it in 16 quarters.
VHCP Management II's Ascendis Pharma A/S position peaked at $59.3M in Q1 2019.
143 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q4 2019.

Based on VHCP Management II's 13F filing for Q4 2019, filed 13 Feb 2020.